Objective: The objective of this study was to answer the following questions: what is the frequency of smooth pursuit dysfunction in schizophrenia in New Zealand; is it comparable to that observed in other populations; is it specific to schizophrenia; and is it represented in major ethnic groups present in New Zealand? Method: Patients with schizophrenia (n = 26) were recruited at five clinical facilities in the Auckland region. Diagnoses were taken from clinical records. Patients'smooth pursuit eye movements while following sinusoidal and triangular wave targets were recorded and their performance compared to a control population (n = 34). Eye movements were scored using the ln(s/n), pursuit gain, and saccadic frequency measures.
Results: Patients with schizophrenia scored significantly worse than controls using the ln(s/n) measure and had significantly higher saccadic frequencies for both targets. Percentile equivalents allow the estimation that about 50% of patients with schizophrenia have smooth pursuit dysfunction (SPD). There was no difference between groups for pursuit gain score, although low gain pursuit was significantly correlated with higher medication in the schizophrenia patient group. There were no differences associated with age, sex or ethnicity. The SPD marker was found in European- and Polynesian-derived New Zealanders.
Conclusions: The results of the present study are consistent with results of previous studies performed elsewhere. Differences are at least partly ascribable to variations in methods. Smooth pursuit dysfunction is a robust marker for schizophrenia. Its application would be particularly useful in the New Zealand context as part of a first admission study looking at the effects of ethnicity on schizophrenia prognosis and on the stability of psychiatric diagnoses.
LevyDLHolzmanPSMatthysseSMendelNREye tracking dysfunction and schizophrenia: a critical perspective. Schizophrenia Bulletin1993; 19:461–653.
2.
AllenJSEye movements and schizophrenia. New Zealand Science Monthly1994; May:12–13.
3.
SzymanskiSKaneJLiebermanJ.Trait markers in schizophrenia: are they diagnostic? In: WidigerTAFrancesAJPincusHA, eds. DSM-IV sourcebook. Washington, DC: American Psychiatric Association, 1994:477–489.
4.
MatthysseSHolzmanPSLangeK.The genetic transmission of schizophrenia: application of Mendelian latent structure analysis to eye tracking dysfunctions in schizophrenia and affective disorders. Journal of Psychiatric Research1986; 20:57–76.
5.
ThakerGKCassadySAdamiHMoranMRossDEEye movements in spectrum personality disorders: comparison of community subjects and relatives of schizophrenic patients. American Journal of Psychiatry1996; 153:362–368.
6.
StarkL.Abnormal patterns of normal eye movements in schizophrenia. Schizophrenia Bulletin1983; 9:55–72.
7.
LevinS.Frontal lobe dysfunction in schizophrenia—I. Eye movement impairments. Journal of Psychiatric Research1984; 18:27–55.
ClementzBAIaconoWGGroveWMThe construct validity of root-mean-square error for quantifying smooth-pursuit eye tracking abnormalities in schizophrenia. Biological Psychiatry1996; 39:448–450.
10.
AllenJSMatsunagaKNakamuraTSchizophrenia, eye movements, and biocultural heterogeneity. Human Biology1990; 62:337–352.
11.
DavisJMComparative doses and costs of antipsychotic medication. Archives of General Psychiatry1976; 33:858–861.
12.
BlackwoodDHRClairSt DMMuirWJDuffyJCAuditory P300 and eye tracking dysfunction in schizophrenic pedigrees. Archives of General Psychiatry1991; 48:899–909.
13.
BahillATStarkL.The trajectories of saccadic eye movements. Scientific American1979; July:108–117.
14.
SweeneyJAClementzBAHaasGLEscobarMDDrakeKFrancesAJEye tracking dysfunction in schizophrenia: characterization of component eye movement abnormalities, diagnostic specificity, and the role of attention. Journal of Abnormal Psychology1994; 103:222–230.
15.
JablenskyASartoriusNErnbergGSchizophrenia: manifestations, incidence and course in different cultures. Psychological Medicine1992; Suppl. 20:1–97.
16.
SachdevPSPsychiatric illness in the New Zealand Maori. Australian and New Zealand Journal of Psychiatry1989; 23:529–541.
17.
HiroaTe Rangi. The passing of the Maori. Transactions and Proceedings of the New Zealand Institute1924; 55:362–375.
18.
BathgateMAlexanderDMitikulenaABormanBRobertsAGriggM.The health of the Pacific islands people in New Zealand. Wellington: Public Health Commission, 1994.
19.
AbelLAFriedmanLJesbergerJMalkiAMeltzerHYQuantitative assessment of smooth pursuit gain and catch-up saccades in schizophrenia and affective disorders. Biological Psychiatry1991; 29:1063–1072.
20.
FairleyNASiegertRSimpsonAWilsonJRoachB.Psychiatric disorder and disability in New Zealand long-stay psychiatric patients. Australian and New Zealand Journal of Psychiatry1993; 27:590–594.
21.
StantonMWJoycePRStability of psychiatric diagnoses in New Zealand psychiatric hospitals. Australian and New Zealand Journal of Psychiatry1993; 27:2–8.